Know Cancer

or
forgot password

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease


N/A
18 Years
N/A
Not Enrolling
Both
Lung Cancer

Thank you

Trial Information

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease


- Participants will undergo a chest computed tomography (CT) scan once a year for a 3-year
period.


Inclusion Criteria:



- 5 years or longer from initial Hodgkin's disease diagnosis

- Current age 18 or older

- Received mediastinal irradiation and/or alkylating-agent based chemotherapy

- Smoking history of 10-pack years or more, or current smoker

- Pre-approval from the participant's insurance company for the CT study

Exclusion Criteria:

- Patients with a history of lung cancer

- Currently receiving treatment for another cancer diagnosis

- Known diagnosis of any metastatic cancer

- Pregnant women

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To prospectively collect data on chest CT screening for patients at increase lung-cancer risk after Hodgkin's disease.

Outcome Time Frame:

3 years

Safety Issue:

No

Principal Investigator

Andrea K. Ng, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dana-Farber Cancer Institute/Brigham and Women's Hospital

Authority:

United States: Institutional Review Board

Study ID:

06-122

NCT ID:

NCT00601146

Start Date:

November 2006

Completion Date:

Related Keywords:

  • Lung Cancer
  • Hodgkin's disease
  • CT scan
  • Hodgkin Disease
  • Lung Neoplasms

Name

Location
Dana-Farber Cancer Institute Boston, Massachusetts  02115
Brigham and Women's Hospital Boston, Massachusetts  02115